Dow Up 0.76% Nasdaq Up 0.69%

Navidea Biopharmaceuticals, Inc (NAVB)

-NYSE MKT
1.36 Down 0.04(2.86%) Oct 24, 4:03PM EDT
Prev Close:1.40
Open:1.41
Bid:1.10 x 22000
Ask:1.51 x 6900
1y Target Est:4.05
Beta:1.1
Next Earnings Date:N/A
Day's Range:1.36 - 1.41
52wk Range:1.11 - 2.25
Volume:267,720
Avg Vol (3m):1,038,610
Market Cap:204.22M
P/E (ttm):N/A
EPS (ttm):-0.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NAVB

Comparison

Symbol% ChgMkt Cap
NAVBDown 2.86%204.22M
LLYUp 2.64%70.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):76.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.26
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision diagnostics and radiopharmaceutical agents. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback